Oxiquim S.A (OXIQUIM) - Net Assets
Based on the latest financial reports, Oxiquim S.A (OXIQUIM) has net assets worth CL$122.98 Billion CLP (≈ $137.54 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CL$241.47 Billion ≈ $270.04 Million USD) and total liabilities (CL$118.48 Billion ≈ $132.50 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Oxiquim S.A's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CL$122.98 Billion |
| % of Total Assets | 50.93% |
| Annual Growth Rate | 6.23% |
| 5-Year Change | 49.23% |
| 10-Year Change | N/A |
| Growth Volatility | 5.1 |
Oxiquim S.A - Net Assets Trend (2014–2024)
This chart illustrates how Oxiquim S.A's net assets have evolved over time, based on quarterly financial data. Also explore Oxiquim S.A assets under control for the complete picture of this company's asset base.
Annual Net Assets for Oxiquim S.A (2014–2024)
The table below shows the annual net assets of Oxiquim S.A from 2014 to 2024. For live valuation and market cap data, see Oxiquim S.A market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CL$116.79 Billion ≈ $130.61 Million |
+8.54% |
| 2023-12-31 | CL$107.60 Billion ≈ $120.33 Million |
+8.87% |
| 2022-12-31 | CL$98.83 Billion ≈ $110.53 Million |
+16.50% |
| 2021-12-31 | CL$84.83 Billion ≈ $94.87 Million |
+8.40% |
| 2020-12-31 | CL$78.26 Billion ≈ $87.52 Million |
+5.35% |
| 2018-12-31 | CL$74.28 Billion ≈ $83.08 Million |
+5.39% |
| 2017-12-31 | CL$70.49 Billion ≈ $78.83 Million |
-0.33% |
| 2016-12-31 | CL$70.72 Billion ≈ $79.08 Million |
+11.47% |
| 2015-12-31 | CL$63.44 Billion ≈ $70.95 Million |
-0.54% |
| 2014-12-31 | CL$63.79 Billion ≈ $71.34 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Oxiquim S.A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 61.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CL$78.18 Billion | 66.95% |
| Other Components | CL$38.60 Billion | 33.05% |
| Total Equity | CL$116.79 Billion | 100.00% |
Oxiquim S.A Competitors by Market Cap
The table below lists competitors of Oxiquim S.A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TA-I Technology Co Ltd
TW:2478
|
$346.70 Million |
|
Samsung Sdi Co Pref
KO:006405
|
$346.80 Million |
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
$346.83 Million |
|
Datavault AI Inc.
NASDAQ:DVLT
|
$346.94 Million |
|
Chinese Maritime Transport Ltd
TW:2612
|
$346.56 Million |
|
Keyfield International Berhad
KLSE:5321
|
$346.48 Million |
|
Incar Financial Service Co. Ltd.
KQ:211050
|
$346.45 Million |
|
G-Tech Optoelectronics Corp
TW:3149
|
$346.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Oxiquim S.A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 107,595,898,000 to 116,786,270,000, a change of 9,190,372,000 (8.5%).
- Net income of 26,317,615,000 contributed positively to equity growth.
- Dividend payments of 17,325,242,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CL$26.32 Billion | +22.53% |
| Dividends Paid | CL$17.33 Billion | -14.83% |
| Other Changes | CL$198.00 Million | +0.17% |
| Total Change | CL$- | 8.54% |
Book Value vs Market Value Analysis
This analysis compares Oxiquim S.A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.65x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.96x to 2.65x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | CL$3144.63 | CL$12453.00 | x |
| 2021-12-31 | CL$3408.76 | CL$12453.00 | x |
| 2022-12-31 | CL$3971.22 | CL$12453.00 | x |
| 2023-12-31 | CL$4323.43 | CL$12453.00 | x |
| 2024-12-31 | CL$4692.72 | CL$12453.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Oxiquim S.A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 22.53%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.18%
- • Asset Turnover: 0.98x
- • Equity Multiplier: 2.05x
- Recent ROE (22.53%) is above the historical average (22.09%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 13.47% | 6.13% | 1.16x | 1.89x | CL$2.21 Billion |
| 2015 | 18.60% | 8.19% | 1.08x | 2.10x | CL$5.46 Billion |
| 2016 | 23.30% | 12.26% | 1.01x | 1.89x | CL$9.41 Billion |
| 2017 | 25.82% | 12.62% | 1.08x | 1.89x | CL$11.15 Billion |
| 2018 | 19.17% | 9.10% | 1.08x | 1.95x | CL$6.81 Billion |
| 2020 | 22.00% | 10.89% | 0.93x | 2.17x | CL$9.39 Billion |
| 2021 | 24.40% | 10.83% | 0.98x | 2.30x | CL$12.22 Billion |
| 2022 | 29.40% | 10.98% | 1.18x | 2.27x | CL$19.18 Billion |
| 2023 | 22.21% | 11.13% | 0.95x | 2.09x | CL$13.14 Billion |
| 2024 | 22.53% | 11.18% | 0.98x | 2.05x | CL$14.64 Billion |
Industry Comparison
This section compares Oxiquim S.A's net assets metrics with peer companies in the Chemicals industry.
No peer company data available for comparison.
About Oxiquim S.A
Oxiquim S.A. produces and sells resins for the wood board industry in Chile. It offers liquid petroleum gas, clean fuels, wood board, animal feed and nutrition, human food, food flexible packaging films, thermoplastic and compostable resins, paints, coating, and adhesives; industrial water, desalination, purification and treatment; pharmaceutical, mining, detergents and cleaning, cellulose and pa… Read more